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Abstract
Background: Verbal autopsy (VA) is an important method for obtaining cause of death information in settings
without vital registration and medical certification of causes of death. An array of methods, including physician
review and computer-automated methods, have been proposed and used. Choosing the best method for VA
requires the appropriate metrics for assessing performance. Currently used metrics such as sensitivity, specificity,
and cause-specific mortality fraction (CSMF) errors do not provide a robust basis for comparison.
Methods: We use simple simulations of populations with three causes of death to demonstrate that most metrics
used in VA validation studies are extremely sensitive to the CSMF composition of the test dataset. Simulations also
demonstrate that an inferior method can appear to have better performance than an alternative due strictly to the
CSMF composition of the test set.
Results: VA methods need to be evaluated across a set of test datasets with widely varying CSMF compositions.
We propose two metrics for assessing the performance of a proposed VA method. For assessing how well a
method does at individual cause of death assignment, we recommend the average chance-corrected concordance
across causes. This metric is insensitive to the CSMF composition of the test sets and corrects for the degree to
which a method will get the cause correct due strictly to chance. For the evaluation of CSMF estimation, we
propose CSMF accuracy. CSMF accuracy is defined as one minus the sum of all absolute CSMF errors across causes
divided by the maximum total error. It is scaled from zero to one and can generalize a method’s CSMF estimation
capability regardless of the number of causes. Performance of a VA method for CSMF estimation by cause can be
assessed by examining the relationship across test datasets between the estimated CSMF and the true CSMF.
Conclusions: With an increasing range of VA methods available, it will be critical to objectively assess their
performance in assigning cause of death. Chance-corrected concordance and CSMF accuracy assessed across a
large number of test datasets with widely varying CSMF composition provide a robust strategy for this assessment.
Keywords: Verbal autopsy, metrics, validation
Background
Verbal autopsy (VA) has been in use in various field stu-
dies, surveillance sites, and national systems for more
than four decades [1-4]. The instruments and analytical
tools used to assign cause of death are rapidly evolving.
New automated methods [4-7] have been proposed and
are in use alongside traditional physician-certified verbal
autopsy (PCVA). With new Bayesian statistical methods
and machine learning approaches being developed, we
can expect a wide range of new methods and refine-
ments of existing methods in the coming years. It will
become increasingly important for users of VA instru-
ments and analytical tools to compare the performance
of all the options in a balanced, objective fashion.
Large, but we argue inadequate validation datasets in
which VA is compared to medical records have been
collected and reported in the literature for China and
Thailand [8,9]. The multisite Population Health Metrics
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tion dataset for neonates, children, and adults in Mex-
ico, Tanzania, India, and the Philippines. These studies,
as opposed to all previous efforts, provide the opportu-
nity to compare VA results to gold standard cause of
death assignment based on strict clinical diagnostic cri-
teria [10]. All of these datasets provide rich empirical
opportunities to assess the validity of existing and pro-
posed VA methods. Robust comparison of performance
requires standardization of the metrics used to assess
the validity of VA and respect of some basic principles
for the validation of empirically-derived approaches.
Many metrics, including cause-specific sensitivity, speci-
ficity, concordance, absolute error in cause-specific mor-
tality fractions (CSMFs), relative error in CSMFs, and
Cohen’s kappa have been reported in the literature
[2,8,9,11-22]. The purpose of this paper is to identify
and discuss the key issues that must be addressed to
choose a set of metrics for VA validation studies and
make recommendations based on this assessment for
future reporting.
A wide array of different types of VA methods has
been proposed. We can classify the various methods
into four groups, based on the nature of the task that
they attempt to perform: 1) individual death cause
assignment to a single cause, which includes PCVA and
variants of Symptom Pattern, Tariff, and machine learn-
ing [2,9,21,23-27]; 2) individual death cause assignment
to multiple causes with probabilities across causes for
each death summing to 100%; 3) direct estimation of
CSMFs without assigning causes to individual deaths;
and 4) combined methods that use both direct estima-
tion of CSMFs and individual cause of death assignment
so that the sum of the individual cause of death assign-
ments equals the CSMFs from direct estimation. Pro-
posed metrics need to be useful for comparing the
performance of methods across this entire spectrum.
Further, the metrics and validation study design needs
to be able to help identify methods that are likely to
perform better than others in many diverse settings with
varying population CSMFs and cause lists.
Published studies on the validity of verbal autopsy
have used a wide variety of measures, many of them
coming from the literature on the evaluation of diagnos-
tic tests. Authors have generally reported measures of
the performance of a VA method for assigning causes to
individual deaths such as sensitivity, specificity, concor-
dance, and more recently, kappa [8,9,11,12,14,16-20]. In
addition, they have used measures to assess how well a
VA method estimates CSMFs, including the sum of the
absolute values of CSMF errors, average CSMF error,
and relative error in CSMFs [2,8,9,11,12,14-17,21,22].
There are many other measures proposed in the litera-
ture on nominal association such as phi, contingency
coefficient, adjusted contingency coefficient, Tschu-
prow’sT ,C r a m e r ’s V, and Matthews correlation coeffi-
cient [28-32]. When applied to the comparison of true
cause and predicted cause, these measures capture in a
single quantity how often the true cause is predicted
correctly as a complex function of misclassification of
the true negatives. In VA, however, different uses, such
as a research study or monitoring population health,
imply different priorities on correct individual cause
assignment or accurate CSMF prediction. For this rea-
son, we do not believe that the measures of nominal
association that produce a single measure reflecting
both will be useful. We focus in this paper on separate
measures of individual cause assignment and CSMF
accuracy following the general VA tradition. This
approach is also required because some of the proposed
VA methods, such as the method of King and Lu [33],
do not predict individual causes of death, only the
CSMFs directly. In other words, metrics that require the
full N by N matrix of true and predicted cause to be
complete cannot be applied to some VA methods.
Methods
Many metrics are a function of the CSMF composition of
a test dataset
We use a simple hypothetical case of a VA method to
demonstrate why some currently-reported metrics may
be difficult to interpret in a robust fashion. This illustra-
tion uses a hypothetical case of a population with three
causes of death: A, B, and C. Imagine a VA method (by
w h i c hw em e a nt h ec o m b i n a t i o no ft h ei n s t r u m e n ta n d
the analytical tool applied to generate cause of death
assignments), method 1, that produces a predicted cause
for each death. Table 1 shows the probability that for a
given true cause, method 1 will assign the death to one
Table 1 The hypothetical method 1 shows the probability
of assigning a death from a true cause to each of the
three possible causes; the hypothetical method 2 differs
only in the higher probability of assigning deaths from
cause A to cause A.
Method 1 Estimated
ABC
True A 0.70 0.03 0.27
B 0.04 0.60 0.36
C 0.065 0.585 0.35
Method 2 Estimated
ABC
True A 0.80 0.02 0.18
B 0.04 0.60 0.36
C 0.065 0.585 0.35
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of these probabilities as the fundamental attribute of a
VA assignment method. Given the matrix of these prob-
abilities and the CSMF composition of a test dataset, we
can easily compute the standard array of metrics,
including sensitivity, specificity, concordance, absolute
error in CSMFs, and relative error in the CSMFs.
We have created 500 test datasets by randomly vary-
ing the cause composition of the test set (using random
draws from an uninformative Dirichlet distribution). We
use the Dirichlet distribution because it creates an even
distribution across all possible combinations of causes
that sum to 100%. By holding constant the probabilities
of classification as a function of each true cause as
shown in Table 1, we have quantified the range of each
metric due purely to changes in the test set cause com-
position. Table 2 shows the mean, median, maximum,
and minimum values of each metric across the ran-
domly-varied cause compositions. Because we are hold-
ing constant the probability of correct and incorrect
classification of each true cause, sensitivity for each
cause in these simulations does not vary. But specificity
for each cause, kappa, overall concordance, summed
absolute CSMF error, and relative CSMF error vary
widely. The ranges are large enough that one cannot
meaningfully compare results of a method from one test
dataset with results for another method in a different
test dataset. We have demonstrated using a simple case
Table 2 Range of values for selected cause-specific and overall metrics of individual cause assignment and CSMF
estimation for two different hypothetical VA assignment methods across 500 test datasets where the cause
composition of the test datasets has been randomly varied.
Method 1 Method 2
Cause A Mean Median Max Min Mean Median Max Min
Sensitivity 0.70 0.70 0.70 0.70 0.80 0.80 0.80 0.80
Specificity 0.95 0.95 0.96 0.94 0.95 0.95 0.96 0.94
Absolute CSMF error 0.08 0.06 0.29 0.00 0.05 0.04 0.19 0.00
Relative CSMF error 0.74 0.24 53.38 0.00 0.71 0.15 53.48 0.00
Chance-corrected concordance 0.55 0.55 0.55 0.55 0.70 0.70 0.70 0.70
Estimated versus true regression Intercept Slope RMSE Intercept Slope RMSE
0.52 0.64 0.00 0.52 0.74 0.00
Cause B Mean Median Max Min Mean Median Max Min
Sensitivity 0.60 0.60 0.60 0.60 0.60 0.60 0.60 0.60
Specificity 0.69 0.69 0.97 0.42 0.70 0.70 0.98 0.42
Absolute CSMF error 0.17 0.15 0.57 0.00 0.17 0.15 0.57 0.00
Relative CSMF error 4.50 0.37 229.07 0.00 4.43 0.37 228.56 0.00
Chance-corrected concordance 0.40 0.40 0.40 0.40 0.40 0.40 0.40 0.40
Estimated versus true regression Intercept Slope RMSE Intercept Slope RMSE
0.30 0.29 0.11 0.30 0.30 0.11
Cause C Mean Median Max Min Mean Median Max Min
Sensitivity 0.35 0.35 0.35 0.35 0.35 0.35 0.35 0.35
Specificity 0.69 0.69 0.73 0.64 0.73 0.73 0.82 0.64
Absolute CSMF error 0.20 0.19 0.63 0.00 0.19 0.17 0.63 0.00
Relative CSMF error 6.75 0.50 793.85 0.00 6.01 0.49 780.54 0.00
Chance-corrected concordance 0.03 0.03 0.03 0.02 0.03 0.03 0.03 0.02
Estimated versus true regression Intercept Slope RMSE Intercept Slope RMSE
0.31 0.03 0.01 0.26 0.08 0.03
Overall causes Mean Median Max Min Mean Median Max Min
Kappa 0.26 0.28 0.47 0.00 0.30 0.33 0.53 0.00
Total absolute CSMF error 0.46 0.45 1.26 0.01 0.42 0.37 1.26 0.03
CSMF accuracy 0.75 0.75 1.00 0.37 0.77 0.80 0.98 0.36
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composition of the test set in principle; in multiple
applications of this approach to different real VA meth-
ods [25-27,34-36] we have also found that this theoreti-
cal result holds true.
Figure 1 compares a measure of performance for
assigning cause to individual deaths, kappa, with the
total absolute error in the CSMFs. This comparison
highlights that a method’s ability to assign individual
causes is not closely related to how well it can estimate
CSMFs. The reason is simple: even when sensitivities
for the three causes are low and therefore kappa is low,
false positives can be balanced by true negatives for
each cause. When false positives and true negatives are
exactly balanced, there will be no error in the estimated
CSMFs. However, these simulations highlight that this
can occur because of the particular and, quite possibly,
idiosyncratic CSMF composition of the test dataset.
Even though results of all standard metrics except
sensitivity are strongly affected by the CSMF composi-
tion of the test dataset, are comparisons of two VA
methods made on one test dataset with one particular
CSMF composition still robust? We can adapt this sim-
ple three-cause simulation environment to explore this
question. Table 1 shows the probabilities of assigning
each true cause to the three predicted causes for a sec-
ond VA method, method 2. This method is superior to
method 1. For true causes B and C it assigns the deaths
in exactly the same proportions as method 1, but for
cause A, sensitivity is higher in method 2, and the rela-
tive pattern of misclassification is the same. Using the
same 500 test datasets with widely varying CSMF com-
positions, Table 3 counts the number of times that
method 1 or 2 has better performance for absolute
CSMF error by cause. In fact, 32%, 36%, and 49% of the
time for cause A, cause B, and cause C, respectively, the
inferior method (method 1) reports smaller absolute
CSMF error. This simple finding illustrates how it could
be extremely misleading to draw conclusions about the
performance of one method compared to another on
the basis of only one test dataset.
In any real comparison of alternative VA methods
with longer cause lists, it is highly likely that for some
causes, sensitivities will be higher and for others, lower.
The pattern of misclassification is also likely to vary
substantially. In these more complicated cases, drawing
conclusions about which method performs better cannot
be made based on one test dataset but needs to be care-
fully assessed for a diverse range of cause compositions
in a series of test datasets.
These three-cause cases also point out that the perfor-
mance of individual cause assignment in predicting the
true cause correctly is quite distinct from how well a
VA method does at predicting the true CSMFs. Clearly,
when sensitivities for each cause equal 100% for all
causes, the CSMFs will be correctly predicted. But for
all realistic cases of VA where sensitivities will be far
below 100%, we need to quantify the performance of a
VA method both at assigning individual causes correctly
and for predicting CSMFs accurately.
We explore metrics for individual cause assignment in
more detail. The key issues examined include correcting
for chance, dealing with the cause composition of the
test dataset, and partial cause assignment metrics. In the
following section, we discuss measures of CSMF accu-
racy, including the choice between measures of absolute
and relative error, adjusting for the number of causes,
comparison to random assignment and taking into
account cause composition of the test set.
Results
Metrics for individual cause assignment
The performance assessment of a method that operates
at the individual level has two components: the fraction
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Figure 1 Kappa versus total absolute CSMF error for method 1
for 500 iterations of experiment with varying true CSMFs. This
graph shows why kappa should not be used as a metric for CSMF
accuracy.
Table 3 The number of times method 1 or 2 has better
performance for the absolute CSMF error in 500
randomly-generated test datasets with varying CSMF
composition.
Cause A B C
Method 121212
Absolute CSMF error 160 340 181 319 247 253
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to that cause and the balance between true negatives
(true deaths from that cause assigned to other causes)
and false positives (deaths from other causes assigned to
that cause). The balance between true negatives and
false positives only matters as it affects the estimates of
the CSMF. Given that we will recommend separate
metrics for the accuracy of CSMF prediction, the only
aspect of individual cause assignment that matters is
whether the true cause is correctly predicted. In Table
1, these are the deaths in the diagonal cells of the
matrix compared to the total number of deaths in each
row. In the literature on diagnostic tests, the number of
deaths in the diagonal cell divided by the total of the
row is defined as the sensitivity for a given cause. The
generalized version for multiple causes has been referred
to as concordance [21,37,38]. As a measure of agree-
ment for a cause, neither sensitivity nor concordance
takes into account agreement expected by chance alone.
I fw eh a daV Aa l g o r i t h mt h a tr a n d o m l ya s s i g n e d
deaths to each cause, we would expect it to have a con-
cordance of (1/n), where n is the number of causes, as
long as there are large numbers for each cause. In other
words, if there are five causes of death and we randomly
assign deaths to each of the five causes, we would be
right 20% of the time. The general concept of correcting
for concordance based on chance can be represented as:
Kj =
P(observed)j − P

expected

j
1 − P

expected

j
Where the P(observed)j is the fraction that are cor-
rectly assigned for a cause j and P(expected)j is the frac-
tion correctly assigned on the basis of chance alone.
There are two choices that affect the exact formulation
of this class of measures: whether to compute an overall
measure of chance-corrected association and/or a cause-
specific measure of chance-corrected association and
how to estimate the association expected on the basis of
chance alone.
There are at least two methods for estimating the P
(expected).
1. Cohen’s kappa calculated P(expected) as:
P

expected

=
n 
k=1

n 
i=1
pik ×
n 
i=1
pki

Where pij is the probability of assigning a death of
cause i to cause j. In addition, P(observed) is calcu-
lated as:
P(observed) =
n 
k=1
pkk
Note that since P(expected) and P(observed) are
defined over all causes, Cohen’s kappa is an overall-
causes measure of chance-corrected association.
2. Cohen’s kappa assumes that the chance prediction
is informed by the true test set cause composition. A
more naïve assumption, perhaps more appropriate
for VA validation studies, is that the method is unin-
formed about the true test composition, and chance
assignment would simply be equal assignment to all
causes. An alternative method for estimating P
(expected) is to assume it is simply (1/n), where n is
the number of causes.
Cohen’s kappa has been reported in the VA literature,
but it is not the most attractive approach to correcting
for chance in VA applications. As shown in Table 2,
Cohen’s kappa is quite sensitive to the cause composi-
tion of the test dataset, while option two above is not at
all sensitive to this cause composition. Furthermore,
Cohen’s kappa provides a measure of association across
all causes and not a cause-specific measure of concor-
dance, although logically this approach to correcting for
chance could be applied at the cause level.
Based on simplicity and the robustness to the CSMF
composition of the test dataset, we propose to measure
chance-corrected concordance for cause j (CCCj) as:
CCCj =

TPj
TPj + TNj

−

1
N

1 −

1
N

Where TP is true positives, TN is true negatives, and
N is the number of causes. TP plus TN equals the true
number of deaths from cause j.
Reporting this measure enhances the comparability
across studies with different numbers of causes. When
there are only a small number of causes, the chance-
corrected concordance will be substantially lower than
sensitivity. When a VA algorithm gets less than (1/n)
fraction of the deaths correct for a cause, it will have a
chance-corrected concordance that is negative. In all
other cases, the chance-corrected concordance will
range from 0 to 1.
In addition to reporting the chance-corrected concor-
dance for each cause, we will also be concerned with
how well a VA method performs overall at individual
cause assignment for most applications of VA. This
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individual cause assignment for a given test dataset of
the form:
OverallCCC =
k 
j=1
wjCCCj and
k 
j=1
wj =1
The question is how to choose the set of weights
across causes to yield an overall summary for a given
test dataset. There are three logical options available:
the CSMFs in the test dataset, a standardized distribu-
tion of CSMFs such as the global cause of death distri-
bution, and equal weights. Using the test set CSMFs
appear to be undesirable, as the results across VA vali-
dation studies would not be comparable. If there is a
positive or negative correlation between the chance-cor-
rected concordances by cause and the CSMFs in the
test set, the overall chance-corrected concordance will
vary substantially. The second option, using weights
equal to the global cause of death distribution as cur-
rently known, is appealing. The problem, however, is
that in many validation studies, not all causes present in
the global distribution are included. This can be handled
as long as the validation study includes categories for
other causes. But in a validation study on three or four
specific causes with residual causes grouped under
“other causes,” the chance-corrected concordance for
“other causes” would dominate the results if these were
standardized to the global cause of death distribution.
An alternative would be to rescale the cause fractions in
the global distribution for each study such that the sum
of the weights on the included causes equals one. But
this would remove some of the appeal of using the glo-
bal CSMFs as weights. The third option, in which the
weights on each cause are equal for all causes included
in the study, is the easiest to implement and the most
comparable. Based on considerations of simplicity of
explanation, ease of implementation, and comparability,
we recommend the overall chance-corrected concor-
dance be calculated as the average of the cause-specific
chance-corrected concordances, namely equal weights,
in the above equation.
Even when the overall chance-corrected concordance
is calculated as the average of the cause-specific chance-
corrected concordances, the CSMF composition of the
t e s ts e tm a yi n f l u e n c et h er e s u l t .S o m em o r ec o m p l e x
VA analytical methods may not have constant probabil-
ities of assignment to causes conditional on the true
cause of death. In other words, it is possible that con-
cordance for a cause may vary as a function of the test
dataset CSMFs. To avoid making the wrong inference
on a method’s performance, we recommend that a set
of 100 or more test datasets be created with varying
CSMF compositions using sampling with replacement of
the test deaths by cause. Draws should be taken from an
uninformative Dirichlet distribution to capture the range
of possible CSMF compositions and sampling with
replacement used to generate a range of test datasets.
For each test dataset, the overall chance-corrected con-
cordance should be estimated and the median value of
these results should be repor t e da st h es i n g l es u m m a r y
measure of individual cause assignment.
Some VA methods proposed or under development
assign probabilities to more than one cause for each
death [33,37]. These probabilities are assigned such that
they sum to one for each death. There is literature on a
range of measures for these types of cases [39,40]. These
take into account the probability attached to the correct
cause, not just its presence in the top k causes. For sim-
plicity and ease of communication, we can compute a
partial death assignment concordance as the fraction of
deaths for which the true cause is included in the top k
causes, ranked by their predicted probability. For exam-
ple, a method could predict for a particular death that it
is 50% tuberculosis, 20% pneumonia, 10% lung cancer,
10% AIDS, 5% heart failure, and 5% other infectious dis-
eases. We can compute the fraction of the time that the
true cause is the top cause (tuberculosis), the top two
causes (tuberculosis or pneumonia), the top three causes,
and so on. By definition, as the number of causes that are
considered for calculating concordance (top two, top
three, top four, etc.) increases, the calculated concor-
dance must increase or at least remain equal.
As for single cause concordance, we should correct
the partial cause concordance for how much better the
VA method is than random assignment. The formula
for the partial concordance from random assignment
takes into account the combinatorics of cases where the
same cause is selected at random more than once and
simplifies to:
PC(k)=
k
N
Where PC(k) is the partial concordance due to ran-
dom assignment for the top k causes, and N is the num-
ber of causes in the study.
The partial chance-corrected concordance for the top
k causes, PCCC(k) becomes:
PCCC(k)=
C −
k
N
1 −
k
N
Where C is the fraction of deaths where the true
cause is in the top k causes assigned to that death. As k
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fact, at the limit where k equals N, the PC(k) will equal
1.0, and the PCCC(k) will not be defined. By computing
the PCCC(k), we facilitate comparisons across studies
with different numbers of causes and perhaps different
choices of k. As for individual cause assignment, median
PCCC(k) across 100 or more test datasets in which the
CSMFs have been sampled from an uninformative
Dirichlet distribution should be reported.
CSMF accuracy
When true negatives for a cause do not equal the false
positives estimated for that same cause, the predicted
CSMF will be too large or too small. A key choice in
the design of metrics for CSMF accuracy is whether we
are interested in absolute or relative errors in the
CSMF. If the true CSMF for a cause is 15% and we pre-
dict 16%, this an error of one percentage point. If, for
another cause, the true CSMF is 1% and we predict 2%,
t h ee r r o ri sa l s oo n ep e r c e n t a g ep o i n t .S h o u l dw eb e
equally concerned about both of these one percentage
point errors? Or is a doubling of the second cause from
1% to 2% a worse error than the 6.7% overestimation of
the cause fraction for the first cause? This is the classic
problem that has been discussed in several fields:
whether we care about absolute or relative errors
[41,42]. The answer is strictly a normative choice; as
such, our answer must depend on how we intend to use
VA results and what the consequences are of making
various types of errors.
What are the potential effects of misclassification
when true negatives do not equal false positives on
population health or well-being? If the size of the bur-
den of a problem influences the allocation of resources
to programs or research or changes the allocation of
managerial or political attention, then inaccurate CSMFs
could affect health or well-being. In this sense, is the
harm from inaccurate CSMFs related to absolute or
relative errors? Financial resources will have less health
impact if we move resources away from cost-effective
intervention areas to less cost-effective areas. Such harm
would be related to the absolute error in the CSMF, not
t h er e l a t i v ee r r o r .I m a g i n eac a s ew h e r ew eu n d e r e s t i -
mate the CSMF by 100 deaths for a cause of death with
a highly cost-effective intervention strategy available.
Because we have underestimated the magnitude of the
cause, fewer resources are allocated to the program
dealing with this cause, and resources are moved to
address a health problem that has been overestimated
but for which the intervention strategy is less cost-effec-
tive. The misallocation of resources translates in this
hypothetical case into 10 fewer lives being saved. The
reduction in the number of lives saved is a negative con-
sequence that can be traced to the misestimation of the
CSMFs. Resources scale to the absolute size of problem
(and cost effectiveness of interventions). In this example,
which can be confirmed in an optimization model, the
negative consequence scales to the absolute error in
cause estimation, not the relative error. In the absence
of a detailed understanding of which causes have more
or less cost-effective intervention strategies and how
over- or underestimation will lead to misallocation of
resources, it appears prudent to treat all deaths misclas-
sified where true negatives and false positives are not in
balance as equally problematic. In other words, we
should be concerned with absolute errors in the CSMFs,
not relative errors. Given that negative consequences
can come from underestimation or overestimation, we
should, in fact, be interested in the absolute value of
absolute errors in the CSMFs across each cause. For a
summary metric across all causes, we could report the
average of the absolute value of the CSMF error.
Absolute errors in the CSMFs will tend to be smaller
the larger the number of causes in the cause list. For
any given cause list, the maximum possible average or
total error would occur when we estimate 100% of all
deaths due to the cause with the smallest true cause
fraction. For any given number of causes, the total of
the absolute value of the CSMF errors across causes will
always be
CSMF Maximum Error =2
	
1 − Minimum
	
CSMFtrue
j



The average of the absolute value of the errors is this
quantity divided by N, where N is the number of causes.
This convenient result means that we can compute the
performance of any VA method compared to the worst
possible method. This comparison is then independent
of the number of causes in the cause list. Therefore, we
define CSMF accuracy as:
CSMFAccuracy =1−
k 
j=1

 CSMFtrue
j − CSMF
pred
j

 
2(1 − Minimum(CSMFtrue
j ))
This quantity will always range from zero to one,
where a value of one means no error in the predicted
CSMFs and a value of zero means the method is equiva-
lent to the worst possible method of assigning cause
fractions.
Cause composition of the test set can matter because
chance assignment does better or worse depending on
the test set. Perhaps more important are two other rea-
sons that CSMF composition can influence the results.
First, as shown in Table 2, even when the percentage
distribution of a true cause is constant across predicted
causes - for example, for true cause A, 50% are assigned
to A, 30% to B, and 20% to C - variation in true CSMFs
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Second, for some of the more complex VA methods, the
probability of the predicted cause conditional on the
true cause will also vary as a function of the cause com-
position of the test set. Since the purpose of VA valida-
tion studies is to identify which method will work in a
variety of population epidemiological conditions, report-
ing CSMF error or CSMF accuracy for one test set
would risk drawing an incorrect inference on relative
performance.
Given that the CSMF composition of the test set can
have multiple influences, to generate robust conclusions
about the performance of one VA method compared to
another, the cause composition of the test set should be
varied using resampling methods. We can use draws
from an uninformative Dirichlet distribution to evenly
sample all possible cause compositions that sum to one.
The Dirichlet distribution can be used because we can
generate widely varying cause compositions of the test
dataset that sum to 100% for any number of causes.
Further, the expected value for each cause of the unin-
formative Dirichlet is equal cause fractions, but for any
given draw from the distribution there is a wide range
of cause fractions. For each sample from the cause com-
position, we can sample the test data with replacement
to generate a new matching dataset with an alternative
cause composition. After generating predictions for each
alternative test dataset using a proposed VA method, we
can compute CSMF accuracy. A summary metric would
be the median CSMF accuracy across the draws. The
median value will be the preferred metric in this case
because CSMF accuracy can take on extreme values for
some cause compositions.
Repeated draws from the uninformative Dirichlet dis-
tribution should be continued until the median value of
CSMF accuracy stabilizes. Graphing the median value as
a function of the number of draws can provide a visual
indication of at what point CSMF accuracy changes little
with further sampling. The number of draws depends on
the tolerance for changes in the median. A reasonable
tolerance is that further draws do not alter the median
value by more than 0.5%.
Many users of verbal autopsy will also be interested in
the robustness of CSMF estimation for specific causes.
CSMF performance can be assessed by examining the
relationship between the estimated CSMF for a cause
and the true CSMF for a cause. Because several hundred
test datasets have been created by sampling from an
uninformative Dirichlet distribution and then sampling
with replacement from the test data, it is possible to
examine the relationship between estimated CSMF and
true CSMF cause by cause. Figure 2 illustrates the rela-
tionship between estimated and true CSMFs using the
hypothetical VA method 1 across the 500 test datasets
for causes A, B, and C. There are three important
aspects that relate to CSMF performance that can be
best understood in terms of the relationship between
the estimated CSMF and the true CSMF:
CSMFestimated = α + β · CSMFtrue + ε
The intercept in the relationship between estimated
CSMF and true CSMF, a, is an indication of how much
a method tends to assign deaths to a cause even when
there are no deaths from that cause in the test dataset.
Some methods tend towards assigning an equal share of
deaths to each cause. These methods will tend to have
large nonzero intercepts that approach in the extreme
(1/n), where n is the number of causes. The slope of the
relationship, b, indicates by how much the estimated
CSMF increases for each one percentage point in the
true CSMF. Because some or many causes are nonzero
intercepts, the slopes for almost all causes for almost all
methods will be below 1. In other words, most methods
will tend to overestimate small causes and underesti-
mate large causes. The slopes, however, will be highly
variable. Finally, the error term in the relationship
between estimated and true CSMF provides an indica-
tion of how much an estimated cause fraction varies
given a particular value of the true cause fraction. Using
Ordinary Least Squares regression, the values for a, b,
and the standard deviation of the error term (root mean
squared error [RMSE]) can be estimated and reported
by cause. These three values provide an easily-inter-
preted assessment of the performance of a VA method
at estimating the CSMF for a given cause.
Discussion
Our explication of performance metrics for VA leads to
the following conclusions. First, for VA methods that
assign individual causes to deaths, chance-corrected
concordance should be reported for each cause, and the
average chance-corrected concordance should be used
as a summary measure of individual cause assignment.
Second, for VA methods that assign multiple causes to
deaths, the partial chance-corrected concordance for the
top k causes should be reported for each cause, and the
average partial chance-corrected concordance for the
top k causes should be used as a summary measure.
Third, for all VA methods, median CSMF accuracy
computed for a set of test datasets with different CSMF
composition drawn from an uninformative Dirichlet dis-
tribution should be reported.
Because some readers of VA validation studies may
not want a single summary measure of performance for
assigning individual causes of death or a single summary
of CSMF estimation, it will be important to make
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true to assigned cause for all the test datasets. While for
most readers this detail will be hard to interpret, it is an
important aspect of transparency for validation studies
to have this information available at least on demand.
For methods that are based on empirical patterns in
the data, such as machine learning, Symptom Pattern,
Tariff, direct CSMF estimation, or combined methods,
great care needs to be taken to ensure that the data
used to test the validity of the proposed method are not
used for developing or “training” the method. These
methods are extremely effective at identifying patterns
in the data and can easily overfit the data. Strict separa-
tion of the test and training data is a critical aspect of
any validation study. To avoid chance results from a
particular train-test split in the data, validation studies
for empirical methods should use multiple train-test
splits and report the distribution of values for chance-
corrected concordance and median CSMF accuracy. It is
also essential to ensure that the CSMF composition of
t h et e s td a t a s e t si ss e l e c t e da tr a n d o ma n di sn o tt h e
same as the CSMF composition of the training datasets.
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Figure 2 Estimated CSMF versus true CSMF for causes A, B, and C using method 1 for 500 iterations of experiment with varying true
CSMFs.
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different train-test splits and varying the CSMF compo-
sition of the test data through resampling can be
combined.
Several published studies [43,44] have used Cohen’s
kappa as a measure of how accurately CSMFs are pre-
dicted by the method. In fact, Cohen’s kappa is a sum-
mary measure of how well individual causes of death
are assigned. CSMF errors of near zero are possible with
kappa values that are less than 0.1. Cohen’s kappa is an
alternative to average chance-corrected concordance; it
is not a measure of CSMF estimation error. Cohen’s
kappa, however, will be influenced by the composition
of the test training set, as illustrated in Table 2, while
average chance-corrected concordance is not affected by
the test set cause composition.
Conclusion
Even if other measures are reported in addition to those
recommended here, inclusion of this standard set of
metrics will facilitate comparison across different studies
with likely different numbers of causes and different
CSMF compositions. The metrics reported here will also
encourage an explicit recognition of the potential trade-
offs for some methods between individual cause assign-
ment and CSMF accuracy. Different users are likely to
attach different importance to these dimensions; making
standardized measurements of both dimensions available
for all VA methods will facilitate choosing among the
different options. These two standard metrics also
reflect the principal information needs of the main users
of cause of death data, namely population-level monitor-
ing of leading causes of death (policy) and risk attribu-
tion in epidemiological enquiries (research). We expect
that standardized metrics will facilitate further methods
innovation in the future by providing a clear answer if a
new method is leading to improved performance either
in the dimension of individual cause assignment or
CSMF accuracy. Future validation studies of verbal
autopsy methods will also have greater credibility, not
only if the appropriate metrics are used, but also if great
care is taken in establishing true gold standard cause of
death assignment. In the absence of rigorous gold stan-
dards, reporting chance-corrected concordance and
CSMF accuracy will remain only measures of similarity
between two imperfect assessments of cause of death.
Robust validation studies require the right metrics as
well as the appropriate study design.
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